Eurohistocyt SRL
Eurohistocyt reported total assets of 73,853 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of Eurohistocyt shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +15 % Total assets +4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Eurohistocyt's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 06 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 02 Aug 2023
- Year ended 31 Dec 2021filed on 23 Sep 2022
Eurohistocyt's financial analysis
- Solvency99.0%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Eurohistocyt
Eurohistocyt's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0875.504.182
- VAT number
- BE0875504182
- Peppol
- Registered · 0208:0875504182 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Aug 2005
- Registered office
- 9120 Beveren-Kruibeke-Zwijndrecht
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Eurohistocyt (SRL) has been based in Beveren-Kruibeke-Zwijndrecht since 2005, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 2,197 € and equity of 73,094 €; its revenue is not published. Its solvency stands at 99.0%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Eurohistocyt
Companies in the same business, of comparable size and area, outside its group.
- Medidat Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 57,897 €
- Lopital België Wholesale of pharmaceutical and medical goods Aartselaar · balance sheet 120,231 €
- PharmSync Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 136,689 €
- Imtec Diagnostics Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 141,739 €
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- NBS Scientific Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 152,659 €
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
Frequently asked questions about Eurohistocyt
What is the revenue of Eurohistocyt?
Eurohistocyt files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Eurohistocyt?
In Belgium, the VAT number is the company number prefixed with BE: BE0875504182 for Eurohistocyt, if the company is VAT-registered. Its company number (CBE) is 0875.504.182.
Where is the registered office of Eurohistocyt?
According to the CBE register, the registered office of Eurohistocyt is in 9120 Beveren-Kruibeke-Zwijndrecht.
What is the equity of Eurohistocyt?
At the close of the 2025 financial year, the equity of Eurohistocyt amounts to 73,094 €, a solvency of 99.0% of total assets.
Who manages Eurohistocyt?
The register lists 1 active mandates at Eurohistocyt. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Eurohistocyt
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →